Stock-Based Compensation | 5. Stock-Based Compensation The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended October 28, 2017 and October 29, 2016 were as follows (in thousands): Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2017 October 29, 2016 October 28, 2017 October 29, 2016 Stock-based compensation expense by type: Stock options $ 8 $ - $ 181 $ 384 Restricted stock unit awards, including performance-based 796 629 2,905 3,237 Employee stock purchases 19 22 75 80 Director deferred compensation 6 24 18 70 Total stock-based compensation expense 829 675 3,179 3,771 Income tax benefit recognized 305 240 1,151 1,363 Stock-based compensation expense, net of income tax $ 524 $ 435 $ 2,028 $ 2,408 In the thirteen and thirty-nine weeks ended October 28, 2017 and October 29, 2016, we granted the following equity awards: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2017 October 29, 2016 October 28, 2017 October 29, 2016 Stock options 18,577 - 38,949 36,359 Restricted stock unit awards - - 108,429 100,775 Performance-based restricted stock unit awards - - 54,900 45,300 Deferred stock units 417 588 904 14,744 At October 28, 2017, the total compensation costs related to nonvested restricted stock unit awards not yet recognized was $6.3 million and the weighted-average period over which such awards are expected to be recognized was 2.4 years. The total compensation costs related to nonvested stock options to be recognized was $0.1 million and the period over which the award is expected to be recognized was 0.9 years at October 28, 2017. Under the 2012 Non-Employee Director Equity Plan (2012 Plan), a total of 3,361 and 2,851 shares of our common stock were awarded during the thirteen and thirty-nine weeks ended October 28, 2017 and October 29, 2016, respectively, as part of the annual equity award to directors in the first quarter. The weighted-average grant date fair value of stock options granted during the thirteen and thirty-nine weeks ended October 28, 2017 was $4.20 and $6.20 per share, respectively. There were no stock options granted during the thirteen weeks ended October 29, 2016. The weighted-average grant date fair value of stock options granted during the thirty-nine weeks ended October 29, 2016 was $10.56 per share. Our employee purchases of common stock, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follow: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 28, 2017 October 29, 2016 October 28, 2017 October 29, 2016 Shares purchased 6,239 3,236 16,984 11,874 Average price per share $ 12.11 $ 29.29 $ 18.00 $ 27.66 Weighted average fair value at grant date $ 4.52 $ 7.25 $ 4.43 $ 6.94 |